C012 New Innovations in Dermatology: What Devices you will be Using in the Next 1-5 Years
DESCRIPTION
This session will be devoted towards examining the cutting-edge changes to our practices in terms of treatments and technologies. This session will emphasize current and forward-looking “game changers” that will transform the delivery of dermatologic care for the benefit of our patients featuring the world leaders creating this innovation.
LEARNING OBJECTIVES
Discuss new treatments in dermatology.
Assess patient needs for new treatments in dermatology.
Predict new devices to become routine parts of clinical practice in the next 1-5 years.
SCHEDULE
1:00 PM
New Innovations in medical dermatology with devices in the next 5 years
Richard Rox Anderson, MD, FAAD
1:15 PM
New Innovations in neurotoxins and soft fillers in the next 5 years
Jeremy Green, MD, FAAD
1:30 PM
New innovations in the treatment and prevention on non-melanoma skin cancers in the next 1-5 years
Mathew M Avram, MD, JD, FAAD
1:35 PM
New innovations for the treatment of hair in the next 1-5 years
Marc R. Avram, MD, FAAD
1:40 PM
New Innovations in tissue tightening in the next 1-5 years
E. Victor Ross Jr., MD, FAAD
1:50 PM
Discussion
Mathew M Avram, MD, JD, FAAD, Richard Rox Anderson, MD, FAAD, Marc R. Avram, MD, FAAD, Jeremy Green, MD, FAAD
2:00 PM
New Innovations in fractional laser devices in the next 5 years
Roy G. Geronemus, MD, FAAD
2:15 PM
Finding, nurturing and funding innovation
Lynn A. Drake, MD, FAAD
2:25 PM
New Innovations for Treatment of Scars with Devices in the Next 1-5 years
David M Ozog, MD, FAAD
2:35 PM
New Innovations in treatment of vascular conditions with devices
Emil A. Tanghetti, MD, FAAD
2:45 PM
New Innovations in the Treatment of Acne with Devices
Fernanda H. Sakamoto, PhD, MD
2:55 PM
Discussion
Lynn A. Drake, MD, FAAD, Roy G. Geronemus, MD, FAAD, David M Ozog, MD, FAAD, Fernanda H. Sakamoto, PhD, MD, Emil A. Tanghetti, MD, FAAD
3:10 PM
New innovations in the treatment of subcutaneous and visceral fat in the next 1-5 years
Lilit Garibyan, PhD, MD, FAAD
3:20 PM
New innovations in the treatment of tattoos and pigment in the next 1-5 years
Eric F. Bernstein, MD, FAAD
3:30 PM
New Innovations for the treatment of body contouring and laxity
Suzanne L Kilmer, MD, FAAD
3:40 PM
New Innovations you weren't expecting over the next 1-5 years
Dieter Manstein, MD, PhD
3:50 PM
Discussion
Eric F. Bernstein, MD, FAAD, Lilit Garibyan, PhD, MD, FAAD, Suzanne L Kilmer, MD, FAAD, Dieter Manstein, MD, PhD
DIRECTOR
Mathew M Avram, MD, JD, FAAD
SPEAKERS
Richard Rox Anderson, MD, FAAD
Marc R. Avram, MD, FAAD
Eric F. Bernstein, MD, FAAD
Jean D.A. Carruthers, MD
Lynn A. Drake, MD, FAAD
Lilit Garibyan, PhD, MD, FAAD
Roy G. Geronemus, MD, FAAD
Jeremy Green, MD, FAAD
Suzanne L Kilmer, MD, FAAD
Dieter Manstein, MD, PhD
David M Ozog, MD, FAAD
E. Victor Ross Jr., MD, FAAD
Fernanda H. Sakamoto, PhD, MD
Emil A. Tanghetti, MD, FAAD
HANDOUTS
DISCLOSURES
Richard Rox Anderson, MD, FAAD
Accure Acne Inc. – Advisory Board(Stock); AVAVA, LLC – Advisory Board(Stock); Blossom Innovations, LLC – Founder(Stock); Brixton Biosciences – Founder(Stock); Cytrellis Biosystems, Inc – Advisory Board(Stock); Massachusetts General Hospital – Employee(Patent royalties or other compensation for Intellectual Property Rights); Sofregen Medical, Inc. – Consultant(Stock Options);
Marc R. Avram, MD, FAAD
L'Oreal – Consultant (1099 relationship)(Honoraria); Lumenis Be Ltd. – Consultant (1099 relationship)(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Rion Aesthetics – Consultant (1099 relationship)(Honoraria);
Mathew M Avram, MD, JD, FAAD
Allergan, Inc – Consultant (1099 relationship)(Fees); Cytrellis Biosystems, Inc – Consultant(Stock), Consultant(Stock Options); La Jolla NanoMedical – Consultant (1099 relationship)(Stock Options); Sofwave – Consultant (1099 relationship)(Stock Options);
Eric F. Bernstein, MD, FAAD
Acclaro Medical – Founder(Stock Options), Investigator(Equipment), Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Stock Options), Investigator(Grants/Research Funding); Joylux – Advisory Board(Stock Options); Novoxel – Advisory Board(Stock Options); Remedly, Inc – Advisory Board(Stock Options);
Jean D.A. Carruthers, MD
Alastin Skincare, Inc – Consultant(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Alphaeon – Investigator(Grants/Research Funding); Bonti – Consultant(No Compensation Received); Fount Bio – Consultant (1099 relationship)(No Compensation Received); Kythera – Consultant(Honoraria); Merz Aesthetics – Consultant(Honoraria), Investigator(Honoraria); Revance Therapeutics, Inc. – Investigator(Honoraria); Sofwave – Consultant (1099 relationship)(Fees);
Lynn A. Drake, MD, FAAD
No financial relationships exist with ineligible companies.
Lilit Garibyan, PhD, MD, FAAD
Absci – Consultant (1099 relationship)(Honoraria); Annecy Bio – Board of Directors(Stock); Brixton Biosciences – Consultant(Fees), Stockholder(Stock); Clarity Cosmetics, Inc. – Stockholder Private Company(No Compensation Received); EyeCool – Stockholder(Stock); Matilda Venture Studio – Board of Directors(Stock);
Roy G. Geronemus, MD, FAAD
Accure, Inc – Stockholder Private Company(No Compensation Received); AVAVA, Inc. – Investigator(No Compensation Received); Sciton Inc. – Investigator(No Compensation Received);
Jeremy Green, MD, FAAD
Allergan, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Amplifica – Investigator(Grants/Research Funding); Appiell Inc. – Advisory Board(Stock Options); Candesant Biomedical, Inc. – Stockholder(Stock); Croma-Pharma GmbH Austria – Investigator(Grants/Research Funding); Evolus, Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Speaker(Honoraria); Galderma USA – Advisory Board(Honoraria); Ipsen – Advisory Board(Honoraria), Investigator(Grants/Research Funding); L'Oréal Research and Innovation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Merz Aesthetics – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Nordberg Medical – Investigator(Grants/Research Funding); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Revelle Aesthetics, Inc. – Advisory Board(Stock Options); Rion Aesthetics – Speaker(Honoraria); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding); Sinclair Pharma – Investigator(Grants/Research Funding); VeraDermics Inc. – Investigator(Grants/Research Funding);
Suzanne L Kilmer, MD, FAAD
Acclaro Medical – Advisory Board(Stock Options); Accure Acne Inc. – Advisory Board(Stock), Investigator(Grants/Research Funding); Allergan Aesthetics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); AVAVA, Inc. – Investigator(No Compensation Received); AVAVA, LLC – Stockholder Private Company(No Compensation Received); Beiersdorf, Inc. – Advisory Board(Honoraria); BellaMia Technologies Inc. – Advisory Board(Honoraria), Advisory Board(Stock Options); BTL Industries, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Caliway Biopharmaceuticals Co., Ltd – Advisory Board(Honoraria); Cynosure-Lutronic – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Cytrellis Biosystems, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Stockholder Private Company(Stock); Engage Technologies – Advisory Board(Stock), Stockholder Private Company(Stock); Galderma – Advisory Board(No Compensation Received); L'Oreal – Investigator(Grants/Research Funding); Lumenis – Advisory Board(Honoraria), Investigator(No Compensation Received); Revance Therapeutics, Inc. – Advisory Board(Stock); Sofwave – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Solta Medical – Investigator(Grants/Research Funding); Solta Medical Inc – Advisory Board(Honoraria);
Dieter Manstein, MD, PhD
AVAVA, LLC – Consultant(Honoraria); Avava, LLC – Stockholder(Stock); Blossom Innovations, LLC – Stockholder(Stock); GME German Medical Engineering GmbH – Stockholder(Stock); R2 Dermatology, Inc. – Consultant(Honoraria), Other(Patent royalties or other compensation for Intellectual Property Rights); Soltego – Other(Stock); Syneron Candela – Other(Patent royalties or other compensation for Intellectual Property Rights); Zeltiq Aesthetics – Other(Patent royalties or other compensation for Intellectual Property Rights);
David M Ozog, MD, FAAD
Biofrontera AG – Investigator(Grants/Research Funding); Cutera – Investigator(Equipment); Galderma USA – Investigator(Grants/Research Funding); Michelson Diagnostics – Investigator(Grants/Research Funding); miRagen Therapeutics, Inc. – Investigator(Grants/Research Funding); Sciton, Inc. – Investigator(Equipment);
E. Victor Ross Jr., MD, FAAD
Acclaro Medical – Investigator(Grants/Research Funding); Benev – Consultant(Honoraria); Cutera, Inc. – Investigator(Equipment); laser optek – Other(Honoraria); laseroptek – Other(Honoraria); Lumenis – Investigator(Equipment), Investigator(Honoraria); Lutronic – Consultant(Honoraria); Venus Concept – Investigator(Grants/Research Funding);
Fernanda H. Sakamoto, PhD, MD
Accure Medical, LLC – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights); AVAVA, LLC – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights); Beiersdorf, Inc. – Advisory Board(Honoraria); Blossom Innovations, LLC – Founder(Patent royalties or other compensation for Intellectual Property Rights); Cytrellis Biosystems, Inc – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights); Follica – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights); Lightwater Biosciences, Inc. – Advisory Board(No Compensation Received), Advisory Board(Stock Options); R2 Dermatology, Inc. – Advisory Board(Stock); Seventh Sense BioSystems – Advisory Board(Stock); Sofregen Medical, Inc. – Advisory Board(Stock);
Emil A. Tanghetti, MD, FAAD
AbbVie – Speaker(Honoraria); Accure Medical, LLC – Investigator(Grants/Research Funding); Accure, Inc – Stockholder Private Company(Stock Options); Aesthetics Biomedical – Advisory Board(Other Financial Benefit); Arcutis Biotherapeutics – Advisory Board(Honoraria), Speaker(Honoraria); Cynosure, Inc. – Consultant(Equipment), Investigator(Equipment); Dermavant Sciences, Inc. – Speaker(Honoraria); Eli Lilly and Company – Speaker(Honoraria); Galderma Research & Development, LLC – Consultant(Honoraria), Speaker(Honoraria); Incyte Corporation – Speaker(Honoraria); Lutronic – Advisory Board(Equipment); Ortho Dermatologics – Advisory Board(Honoraria), Speaker(Honoraria); Pfizer Inc. – Speaker(Honoraria); Quanta System S.p.A – Consultant(Equipment);